IP Library Granted Patent US 10,973,443
Granted Patent B2
US 10,973,443 · App. 15/963,828 · Granted Apr 13, 2021

Sensor inserter assembly

Inventors: Jeffery V. Funderburk (Stevenson Ranch, CA); Duane O. Yamaski (El Cerrito, CA); Brian VanHiel (Marietta, GA); Stephen J. Flynn (Peachtree City, GA)
Assignee: ABBOTT DIABETES CARE INC.
A61B5/14532A61B5/1451A61B5/1473A61B5/14542A61B5/14546A61B5/6833A61B5/6849A61B17/3468G16H10/40G16H50/00G16H50/30A61M2205/3507A61M2230/201A61N1/05G16H10/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,973,443
App. No.
15/963,828
Granted
Apr 13, 2021
Kind
B2
Abstract

An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte, such as blood glucose. An inserter having a retractable introducer is provided for subcutaneously implanting the sensor in a predictable and reliable fashion.

Claims (39)

1. A method of using an inserter device to insert a transcutaneous glucose sensor into a user, the inserter device comprising an actuator button, a slidable shuttle, a first spring, a second spring having a top end in contact with the slidable shuttle, and a sharp, and the method comprising:

adhering an adhesive portion of a mount to skin of the user while the mount is coupled with the inserter device, wherein the mount is configured to receive an electronics component housing;

depressing the actuator button of the inserter device after the adhesive portion of the mount is adhered to the skin of the user, wherein depression of the actuator button causes automatic advancement of the slidable shuttle, the sharp, and the transcutaneous glucose sensor by the first spring, such that the sharp and the transcutaneous glucose sensor advance through an opening in the mount and into the user, wherein the automatic advancement is followed by automatic retraction of the sharp from within the user;

removing the inserter device from the mount while the transcutaneous glucose sensor remains in the user; and

inserting the electronics component housing into the mount after the inserter device is removed from the mount.

2. The method of claim 1 , wherein depression of the actuator button causes a release of energy stored in the first spring.

3. The method of claim 2 , wherein the first spring is a coil spring.

4. The method of claim 1 , further comprising removing a liner from the adhesive portion prior to adhering the adhesive portion of the mount to the skin of the user.

5. The method of claim 1 , wherein the inserter device further comprises:

a housing coupled with the actuator button; and

a base coupled with the mount and the housing, the base comprising guides, wherein depressing the actuator button causes automatic advancement of the slidable shuttle along the guides of the base.

6. The method of claim 1 , wherein the slidable shuttle is coupled with the sharp and the transcutaneous glucose sensor is received within the sharp.

7. The method of claim 1 , wherein the transcutaneous glucose sensor is slidably received within the sharp.

8. The method of claim 1 , wherein depression of the actuator button causes the automatic advancement of the sharp and the transcutaneous glucose sensor through the opening in the mount such that a first portion of the transcutaneous glucose sensor couples with the mount and a second portion of the transcutaneous glucose sensor is implanted into the user.

9. The method of claim 1 , wherein inserting the electronics component housing into the mount comprises electrically connecting electronics in the electronics component housing with the transcutaneous glucose sensor.

10. The method of claim 9 , wherein the electronics comprise a transmitter.

11. The method of claim 1 , wherein removing the inserter device from the mount while the transcutaneous glucose sensor remains in the user comprises unlatching the inserter device from the mount.

12. The method of claim 1 , wherein the mount comprises a cavity for receiving the electronics component housing.

13. An assembly comprising:

an inserter device comprising an actuator button, a slidable shuttle, a first spring, a second spring having a top end in contact with the slidable shuttle, and a sharp;

a transcutaneous glucose sensor; and

a mount releasably coupled with the inserter device, wherein the mount comprises an adhesive portion configured to adhere to skin of a user while the mount is coupled with the inserter device,

wherein the actuator button, when depressed, is configured to cause automatic advancement of the slidable shuttle, the sharp, and the transcutaneous glucose sensor by the first spring, such that the sharp and the transcutaneous glucose sensor advance through an opening in the mount and into the user,

wherein the second spring is configured to expand and cause automatic retraction of the sharp in a direction away from the skin of the user while the transcutaneous glucose sensor remains in the user,

wherein the mount is configured for positioning on the skin of the user prior to advancing the sharp and the transcutaneous glucose sensor through the opening in the mount,

wherein the inserter device is configured to be removed from the mount while the transcutaneous glucose sensor remains in the user, and

wherein the mount is further configured to receive an electronics component housing into the mount after the inserter device is removed from the mount.

14. The assembly of claim 13 , wherein the actuator button is further configured to cause a release of energy stored in the first spring when the actuator button is depressed.

15. The assembly of claim 13 , wherein the first spring is a coil spring.

16. The assembly of claim 13 , further comprising a liner removably attached to the adhesive portion of the mount, wherein the liner is configured to be removed from the adhesive portion before the adhesive portion is adhered to the skin of the user.

17. The assembly of claim 13 , wherein the inserter device further comprises:

a housing coupled with the actuator button; and

a base coupled with the mount and the housing, the base comprising guides, wherein the actuator button is further configured to cause the automatic advancement of the slidable shuttle along the guides of the base when the actuator button is depressed.

18. The assembly of claim 13 , wherein the slidable shuttle is coupled with the sharp and the transcutaneous glucose sensor is received within the sharp.

19. The assembly of claim 13 , wherein the transcutaneous glucose sensor is slidably received within the sharp.

20. The assembly of claim 13 , wherein the actuator button is further configured to cause the automatic advancement of the sharp and the transcutaneous glucose sensor through the opening in the mount such that a first portion of the transcutaneous glucose sensor couples with the mount and a second portion of the transcutaneous glucose sensor is implanted into the user.

21. The assembly of claim 13 , wherein the transcutaneous glucose sensor is configured to be electrically connected to electronics in the electronics component housing when the electronics component housing is received into the mount.

22. The assembly of claim 13 , wherein the inserter device is configured to be removed from the mount by unlatching the inserter device from the mount.

23. The assembly of claim 13 , wherein the mount further comprises a cavity for receiving the electronics component housing.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2020
From: FUNDERBURK, JEFFERY V.; YAMASAKI, DUANE O.; VANHIEL, BRIAN; FLYNN, STEPHEN J.; KELEMEN, BRADLEY D.
To: THERASENSE, INC.
Reel/Frame 052965/0879 →
CHANGE OF NAME Recorded Jun 17, 2020
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 052970/0366 →
Continuity (6)
Continuation 14244831 · Apr 3, 2014
Continuation 12538067 · Aug 7, 2009
Continuation 11899917 · Sep 6, 2007
Continuation 10703214 · Nov 5, 2003
Provisional Application 60424099 · Nov 5, 2002
Related Publication 20190000356A1 · Jan 3, 2019
Cited By (62)
US 1,057,153 US 12,239,442 US 12,239,463 US 12,268,496 US 12,274,548 US 12,274,549 US 12,279,866 US 12,279,867 US 12,279,868 US 12,279,894 US 12,285,251 US 12,285,252 US 12,310,722 US 12,313,622 US 12,315,630 US 12,326,441 US 12,329,522 US 12,336,812 US 12,343,140 US 12,350,042 US 12,369,821 US 12,390,132 US 12,408,847 US 12,414,713 US 12,436,127 US 12,440,173 US 12,462,006 US 12,465,251 US 12,471,850 US 12,478,296 US 12,482,558 US 12,495,993 US 12,514,448 US 12,521,041 US 12,533,080 US 12,558,007 US 12,558,122 US 12,562,273 US 12,569,166 US 12,569,168 US 12,569,173 US 12,575,763 US 12,575,856 US 12,576,599 US 12,582,334 US 12,588,928 US 12,589,204 US 12,599,317 US 12,605,185 US 12,605,186 US 12,610,742 US 12,611,121 US 12,611,125 US 12,616,395 US 12,616,396 US 12,616,397 US 12,629,173 US 12,667,286 US 12,690,789 US 12,702,332 US 12,727,760 US 12,727,833